Mineralys Therapeutics, Inc.MLYS
Close of Friday, October 23, 2026 · Mineralys Therapeutics, Inc. is trading below its Pivot, OnlyAlpha's long-term trend line.
Price
$20.55
vs its Pivot
-24.8%
OnlyAlpha Score
37
Trend
Below its Pivot
Last 12 months. Solid line: price. Dashed green: the Pivot.
Returns
| 1 month | Year to date | 1 year | 3 years / yr | 5 years / yr |
|---|---|---|---|---|
| -22.7% | -43.4% | -51.1% | — | — |
No dividend in the last 12 months.
Who runs and owns it
In these funds
IBB · 0.10%IWM · 0.05%
Big investors that own it (latest 13F)
| RA Capital Peter Kolchinsky | 1.8% of holdings |
| OrbiMed Carl Gordon | 1.1% of holdings |
Get MLYS in your free daily emailAfter every close: whether MLYS is above or below its Pivot, its OnlyAlpha Score, and any new buy or sell signal, along with the rest of your list.
Track MLYS free → Full Stock check
Track MLYS free → Full Stock check